PL1899352T3 - Pochodne 1-[2’,3’-dideoksy 3’c-(hydroksymetylo)-beta d-erytropentofuranozylo] cytozyny jako inhibitory hiv - Google Patents

Pochodne 1-[2’,3’-dideoksy 3’c-(hydroksymetylo)-beta d-erytropentofuranozylo] cytozyny jako inhibitory hiv

Info

Publication number
PL1899352T3
PL1899352T3 PL06777595T PL06777595T PL1899352T3 PL 1899352 T3 PL1899352 T3 PL 1899352T3 PL 06777595 T PL06777595 T PL 06777595T PL 06777595 T PL06777595 T PL 06777595T PL 1899352 T3 PL1899352 T3 PL 1899352T3
Authority
PL
Poland
Prior art keywords
pentofuranosyl
erythro
dideoxy
hydroxymethyl
beta
Prior art date
Application number
PL06777595T
Other languages
English (en)
Inventor
Xiao-Xiong Zhou
Christer Sahlberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of PL1899352T3 publication Critical patent/PL1899352T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL06777595T 2005-07-07 2006-07-05 Pochodne 1-[2’,3’-dideoksy 3’c-(hydroksymetylo)-beta d-erytropentofuranozylo] cytozyny jako inhibitory hiv PL1899352T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0513835.9A GB0513835D0 (en) 2005-07-07 2005-07-07 HIV inhibitors
EP06777595A EP1899352B1 (en) 2005-07-07 2006-07-05 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors
PCT/EP2006/063919 WO2007006707A1 (en) 2005-07-07 2006-07-05 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
PL1899352T3 true PL1899352T3 (pl) 2012-03-30

Family

ID=34856749

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06777595T PL1899352T3 (pl) 2005-07-07 2006-07-05 Pochodne 1-[2’,3’-dideoksy 3’c-(hydroksymetylo)-beta d-erytropentofuranozylo] cytozyny jako inhibitory hiv

Country Status (19)

Country Link
US (2) US7888367B2 (pl)
EP (2) EP1899352B1 (pl)
JP (1) JP5174660B2 (pl)
CN (1) CN101213198B (pl)
AT (1) ATE527267T1 (pl)
AU (1) AU2006268743C1 (pl)
BR (1) BRPI0612678A2 (pl)
CA (1) CA2610210A1 (pl)
CY (1) CY1112164T1 (pl)
DK (1) DK1899352T3 (pl)
ES (1) ES2373743T3 (pl)
GB (1) GB0513835D0 (pl)
HK (1) HK1122798A1 (pl)
HR (1) HRP20110830T1 (pl)
MX (1) MX2008000221A (pl)
PL (1) PL1899352T3 (pl)
PT (1) PT1899352E (pl)
WO (1) WO2007006707A1 (pl)
ZA (1) ZA200710662B (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810907D0 (en) 1988-05-09 1988-06-15 British Telecomm Fluoride glass optical coupler & method of manufacture
ZA902631B (en) * 1989-04-06 1990-12-28 Bristol Myers Squibb Co 3'-substituted methyl nucleosides as antiviral agents
US5866775A (en) 1990-09-28 1999-02-02 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
JPH10501217A (ja) * 1994-05-31 1998-02-03 メディヴィル・アクチボラグ Hivの被爆後阻止
US5612319A (en) 1994-05-31 1997-03-18 Medivir Ab Postexposure prevention of HIV infection or seroconversion
TR200000398T2 (tr) 1997-08-15 2000-07-21 Medivir Ab Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları.
DE60136620D1 (de) * 2000-04-13 2009-01-02 Pharmasset Inc 3 oder 2 hydroxymethyl substituierte nucleoside derivate und ihre verwendung zur behandlung von virusinfektionen
US7109931B2 (en) 2004-06-18 2006-09-19 Centurion Wireless Technologies, Inc. Method and apparatus to control an antenna efficiency test device
EA011039B1 (ru) * 2004-12-30 2008-12-30 Медивир Аб Приемлемые для лечения вич соединения

Also Published As

Publication number Publication date
EP1899352A1 (en) 2008-03-19
JP5174660B2 (ja) 2013-04-03
CA2610210A1 (en) 2007-01-18
CY1112164T1 (el) 2015-12-09
MX2008000221A (es) 2008-03-18
GB0513835D0 (en) 2005-08-10
ATE527267T1 (de) 2011-10-15
US20080221140A1 (en) 2008-09-11
DK1899352T3 (da) 2012-01-30
PT1899352E (pt) 2012-01-05
US20110112294A1 (en) 2011-05-12
CN101213198A (zh) 2008-07-02
BRPI0612678A2 (pt) 2010-11-30
US7888367B2 (en) 2011-02-15
HRP20110830T1 (hr) 2011-12-31
WO2007006707A1 (en) 2007-01-18
US8143396B2 (en) 2012-03-27
EP1899352B1 (en) 2011-10-05
EP2336135A2 (en) 2011-06-22
EP2336135A3 (en) 2011-07-27
JP2008545002A (ja) 2008-12-11
CN101213198B (zh) 2011-08-03
AU2006268743B2 (en) 2010-07-29
HK1122798A1 (en) 2009-05-29
AU2006268743A1 (en) 2007-01-18
AU2006268743C1 (en) 2010-12-16
ZA200710662B (en) 2008-11-26
ES2373743T3 (es) 2012-02-08

Similar Documents

Publication Publication Date Title
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
TW200728276A (en) Oxindole derivatives
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
TW200730494A (en) Novel compounds
GEP20094736B (en) Prodrugs of piperazine and substituted piperidine antiviral agents
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
UY30310A1 (es) Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
TW200502230A (en) Dual nk1/nk3 derivatives
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
DOP2010000137A (es) Derivados de 1,2,3-triazol como inhibidores de estearoil-coenzima a desaturasa
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
GB0710121D0 (en) Antifungal agents
TW200639156A (en) New compounds
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
BRPI0607214A2 (pt) derivados de 2-(4-cianofenilamino) pirimidina inibidores de hiv
MXPA04006041A (es) Antivirales de piridoquinoxalina.
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
DE60231426D1 (de) Solubilisierte topoisomerase-gift-mittel
PT2366393E (pt) Roflumilaste para o tratamento da hipertensão pulmonar
MX2010001304A (es) Compuestos terapeuticos.
BR0200536A (pt) Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
EP1987834A3 (en) Substituted piperidines as therapeutic compounds
ZA200710662B (en) 1-[2', 3'-dideoxy-3' C-(hydroxymethyl)-beta-d-erythropentofuranosyl] cytosine derivatives as HIV inhibitors